Abstract:Abstract Background Regions of high metabolic activity within a tumor can increase tumor perfusion. Dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) and 18Fluorodeoxyglucose (FDG) positron emission tomography (PET) are imaging methods used in cancer diagnosis; the former identifies perfusion of the tumor microenvironment and the latter provides a coarse readout of glucose metabolic activity. Here, we perform a pilot analysis in a unique cohort of patients who underwent DCE-MRI, 18FDG-PET and 64Cu-DOTA-Traztuzumab. We characterize the performance of our perfusion model SimBioSys-Microvasculature (SBS-MV). We use this model in 3D simulations of individual HER2+ breast cancer patients to forecast response to neoadjuvant chemotherapy (NAT). Methods SBS-MV is a modified Tofts model for pharmacokinetic modeling of DCE-MRI data, utilizing a tissue segmentation model developed in-house to inform parameter fits and ensure that the derived parameters fall within acceptable values on a tissue-by-tissue level. We evaluated the stability of the SBS-MV model by analyzing a separate cohort of 10 patients who underwent ultrafast DCE-MRI. By undersampling the original high temporal resolution data, we mimicked possible variation in standard-of-care (SoC) DCE studies and accessed the variability of our fits with respect to different subsets. Next, we analyzed data from a different cohort of 18 patients, each of whom underwent a pre-NAT SoC DCE-MRI study, a mid-treatment FDG PET study, and a mid-treatment 64Cu-DOTA-Trastuzumab study during treatment. Tissue segmentation and SBS-MV fits were performed on the pre-NAT DCE-MRI. Tightly cropped boxes encompassing the tumor in the 3D SBS-MV volumes and the PET volumes were created. Using these identified regions, all summary statistics were calculated and cross-correlated between imaging modalities. Results SBS-MV was stable to SoC-mimicking temporally undersampled ultrafast DCE-MRI series, demonstrating relatively little variability in the output parameters (a voxel wise median deviation of approximately 0.005 min−1). Further, we demonstrate that SBS-MV parameters (Ktrans, ve) are correlated with FDG SUVSA and 64Cu SUVSA. The glucose concentrations used in the biophysical simulations, which are derived from SBS-MV fits, were correlated with FDG SUVSA, indicating that downstream applications of the SBS-MV models still carry this perfusion information. Finally, using SBS-MV, our biophysical simulations of HER2-targeted therapy accurately predict patient response. In this small cohort, our biophysical simulations performed well, yielding predictive accuracy of 0.83 (sensitivity=0.83, specificity=0.83). Conclusion Our MV model extracts biologically meaningful perfusion parameters from standard clinical DCE-MRI time series, providing the same benefits of a comprehensive kinetic analysis without impacting clinical workflow. This approach could be used in research and clinical settings, offering actionable information on what drives individual patient therapeutic response for a more personalized care. Citation Format: John Whitman, Vikram Adhikarla, Russell Rockne, Lusine Tumyan, Joanne Mortimer, Wei Huang, Dorys Lopez Ramos, Joseph R. Peterson, John A. Cole. DCE-MRI-based biophysical simulation to forecast NAT response in HER2+ breast cancer patients, with glucose characterization and orthogonal validation using FDG-PET and 64Cu studies [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Advances in Breast Cancer Research; 2023 Oct 19-22; San Diego, California. Philadelphia (PA): AACR; Cancer Res 2024;84(3 Suppl_1):Abstract nr A024.

Dynamic 2-deoxy-D-glucose-enhanced multispectral optoacoustic tomography for assessing metabolism and vascular hemodynamics of breast cancer

A Spectroscopic Technique to Simultaneously Characterize Fatty Acid Uptake, Mitochondrial Activity, Vascularity, and Oxygen Saturation for Longitudinal Studies In Vivo

Resolution of Spatial and Temporal Heterogeneity in Bevacizumab-Treated Breast Tumors by Eigenspectra Multispectral Optoacoustic Tomography

Preclinical multi‐physiologic monitoring of immediate‐early responses to diverse treatment strategies in breast cancer by optoacoustic imaging

Abstract C016: Optical Techniques to Democratize Intravital Quantification of Metabolic Heterogeneity

Dynamic Glucose Enhanced Imaging using Direct Water Saturation

Abstract A024: DCE-MRI-based biophysical simulation to forecast NAT response in HER2+ breast cancer patients, with glucose characterization and orthogonal validation using FDG-PET and 64Cu studies

Measurement of Hemoglobin Saturation in Tumor Microvasculature in Preclinical Models Using Hyperspectral Imaging

Optical imaging of tumor vascularity associated with proliferation and glucose metabolism in early breast cancer: clinical application of total hemoglobin measurements in the breast

Diffuse Optical Monitoring of Blood Flow and Oxygenation in Human Breast Cancer During Early Stages of Neoadjuvant Chemotherapy.

High-resolution optoacoustic imaging of tissue responses to vascular-targeted therapies

Noninvasive Monitoring of Microvascular Changes with Partial Irradiation Using Dynamic Contrast-Enhanced and Blood Oxygen Level-Dependent Magnetic Resonance Imaging.

Value of Dynamic MRI in Monitoring the Microenvironmental Changes of Anti-Vascular Therapy in a Xenograft Model

Radiosensitizing oxygenation changes in murine tumors treated with VEGF-ablation therapy are measurable using oxygen enhanced-MRI (OE-MRI)

Multi-Modal Investigation of Metabolism in Murine Breast Cancer Cell Lines Using Fluorescence Lifetime Microscopy and Hyperpolarized 13C-Pyruvate Magnetic Resonance Spectroscopy

Concurrent fluorescence and volumetric optoacoustic tomography of nanoagent perfusion and bio-distribution in solid tumors

WST11 Vascular Targeted Photodynamic Therapy Effect Monitoring by Multispectral Optoacoustic Tomography (MSOT) in Mice

In Vivo Evaluation of Combertestatin A-4 Phosphate for Lung Cancer by Bioluminescence Imaging and Multispectral Optoacoustic Tomography

Oxygen-Enhanced Optoacoustic Tomography Reveals the Effectiveness of Targeting Heme and Oxidative Phosphorylation at Normalizing Tumor Vascular Oxygenation

Deuterium MRSI characterizations of glucose metabolism in orthotopic pancreatic cancer mouse models

Simultaneous characterization of tumor cellularity and the Warburg effect with PET, MRI and hyperpolarized 13C-MRSI